Results 221 to 230 of about 220,826 (265)
Some of the next articles are maybe not open access.
LUPUS AND NON‐LUPUS CUTANEOUS MANIFESTATIONS IN SYSTEMIC LUPUS ERYTHEMATOSUS
Australian and New Zealand Journal of Medicine, 1987Abstract Mucocutaneous manifestations occur frequently in systemic lupus erythematosus (SLE). Common non‐lupus dermatoses may be confused with lupus rashes, with important clinical consequences. A study of 84 consecutive patients with SLE was performed to determine the comparative frequency of lupus and non‐lupus mucocutaneous abnormalities, the ...
C, Weinstein +5 more
openaire +2 more sources
Systemic lupus erythematosus and “lupus dyslipoproteinemia”
Autoimmunity Reviews, 2008A growing body of evidences reinforces the close link between systemic lupus erythematosus (SLE) and atherosclerosis which is due to traditional and nontraditional risk factors for cardiovascular diseases. It is now recognized that SLE has a particular pattern of dyslipoproteinemia characterized by low HDL levels and increased triglycerides, which is ...
Jozélio Freire, de Carvalho +2 more
openaire +2 more sources
Lupus pregnancies and neonatal lupus
Springer Seminars in Immunopathology, 1994In the past two decades the diagnosis of systemic lupus erythematosus (SLE) has become easier to make and more certain when made. Advances in treatment have permitted patients with SLE to live longer and healthier lives. New clinical research has also described the role that some autoantibodies associated with SLE have on fetal well-being. As a result,
openaire +2 more sources
Archives of Dermatology, 1972
Lupus erythematosus (LE) is a multisystem disease. Genetic predisposition, altered immunity, hormones, drugs, viruses, and ultraviolet light all may play a role in etiology. A wide range of cutaneous lesions occur, and variants such as subacute cutaneous LE, complement-deficient LE, and neonatal LE have recently been emphasized.
openaire +3 more sources
Lupus erythematosus (LE) is a multisystem disease. Genetic predisposition, altered immunity, hormones, drugs, viruses, and ultraviolet light all may play a role in etiology. A wide range of cutaneous lesions occur, and variants such as subacute cutaneous LE, complement-deficient LE, and neonatal LE have recently been emphasized.
openaire +3 more sources
Animal Models of Lupus and Lupus Nephritis
Current Pharmaceutical Design, 2015This article reviews the commonly used murine strains for studying lupus and lupus nephritis, including strains that develop lupus spontaneously, congenic strains, induced models of lupus, as well as genetically engineered mouse models of lupus bearing transgenes or knockouts.
Yong, Du +3 more
openaire +2 more sources
Current Rheumatology Reports, 2001
Nervous system disease in patients who have systemic lupus erythematosus (SLE) spans a wide spectrum of neurologic (N) and psychiatric (P) features that may be attributed to a primary manifestation of SLE, complications of the disease or its therapy, or a coincidental disease process.
openaire +3 more sources
Nervous system disease in patients who have systemic lupus erythematosus (SLE) spans a wide spectrum of neurologic (N) and psychiatric (P) features that may be attributed to a primary manifestation of SLE, complications of the disease or its therapy, or a coincidental disease process.
openaire +3 more sources
Current Rheumatology Reports, 2016
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease known for its clinical heterogeneity. Over time, new insights into the complex genetic origin of SLE have started to explain some of this clinical variability. These findings, reviewed here, have also yielded important understanding in the immune mechanisms behind SLE pathogenesis ...
openaire +2 more sources
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease known for its clinical heterogeneity. Over time, new insights into the complex genetic origin of SLE have started to explain some of this clinical variability. These findings, reviewed here, have also yielded important understanding in the immune mechanisms behind SLE pathogenesis ...
openaire +2 more sources
Rheumatic Disease Clinics of North America, 2021
Large cohorts with diverse ethnic backgrounds and heterogenous clinical features have provided the real-life data about the safety and efficacy of various treatment regimens for systemic lupus erythematosus (SLE). There are multiple well-established regional, national, and international lupus cohorts that have made significant contributions to the ...
Christopher, Redmond +2 more
openaire +2 more sources
Large cohorts with diverse ethnic backgrounds and heterogenous clinical features have provided the real-life data about the safety and efficacy of various treatment regimens for systemic lupus erythematosus (SLE). There are multiple well-established regional, national, and international lupus cohorts that have made significant contributions to the ...
Christopher, Redmond +2 more
openaire +2 more sources
Muscle & Nerve, 1982
AbstractEleven patients met rigid criteria for having both polymyositis and systemic lupus erythematosus (SLE). The patients differed little in clinical features when compared with patients who had SLE and polymyositis in a previously reported series.
R A, Foote, S M, Kimbrough, J C, Stevens
openaire +2 more sources
AbstractEleven patients met rigid criteria for having both polymyositis and systemic lupus erythematosus (SLE). The patients differed little in clinical features when compared with patients who had SLE and polymyositis in a previously reported series.
R A, Foote, S M, Kimbrough, J C, Stevens
openaire +2 more sources